Malcolm Macartney

Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity

Patrick Dorr, Mike Westby, Susan Dobbs et al. · Antimicrobial Agents and Chemotherapy · 2005 · 1.1K citations

Medicine, Medicinal Chemistry, Pharmacology +17

COMPARISON OF A NEW QUANTITATIVE CYTOMEGALOVIRUS DNA ASSAY WITH OTHER DETECTION METHODS

Malcolm Macartney, Edward Gane, Bernard Portmann et al. · Transplantation · 1997 · 22 citations

Medicine, Microbiology, Pathology +17

Evaluation of sequencing of HCV core/E1, NS5A and NS5B as a genotype predictive tool in comparison with commercial assays targeting 5′UTR

Adele McCormick, Malcolm Macartney, Ikran Abdi-Abshir et al. · Journal of Clinical Virology · 2015 · 19 citations

Life Sciences, Genetics, Infectious Diseases +16

Prevalence of Baseline Polymorphisms for Potential Resistance to NS5A Inhibitors in Drug-Naive Individuals Infected with Hepatitis C Genotypes 1–4

Adele McCormick, Lawrence Wang, Malcolm Macartney et al. · Antiviral Therapy · 2014 · 17 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Chapter 2 CCR5 Pharmacology Methodologies and Associated Applications

Roy Mansfield, Sarah Able, Paul Griffin et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 2009 · 16 citations

Medicine, Medicinal Chemistry, Pharmacology +13